Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration

Distribution of vaccines which require refrigerated or frozen storage can be challenging and expensive. The adenovirus vector platform has been widely used for COVID-19 vaccines while several further candidate vaccines using the platform are in clinical development. In current liquid formulations, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cheng, Berg, Adam, Joe, Carina C. D., Dalby, Paul A., Douglas, Alexander D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240132/
https://www.ncbi.nlm.nih.gov/pubmed/37277337
http://dx.doi.org/10.1038/s41541-023-00674-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240132/
https://www.ncbi.nlm.nih.gov/pubmed/37277337
http://dx.doi.org/10.1038/s41541-023-00674-2

Ejemplares similares